Annual SG&A
$33.30 M
+$752.00 K+2.31%
31 December 2023
Summary:
Athira Pharma annual selling, general & administrative expenses is currently $33.30 million, with the most recent change of +$752.00 thousand (+2.31%) on 31 December 2023. During the last 3 years, it has risen by +$26.59 million (+396.41%). ATHA annual SG&A is now at all-time high.ATHA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$7.57 M
+$1.70 M+28.91%
30 September 2024
Summary:
Athira Pharma quarterly selling, general & administrative expenses is currently $7.57 million, with the most recent change of +$1.70 million (+28.91%) on 30 September 2024. Over the past year, it has dropped by -$268.00 thousand (-3.42%). ATHA quarterly SG&A is now -24.47% below its all-time high of $10.03 million, reached on 30 June 2023.ATHA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.40 B
-$109.22 M-8.47%
30 September 2024
Summary:
Athira Pharma TTM selling, general & administrative expenses is currently -$1.40 billion, with the most recent change of -$109.22 million (-8.47%) on 30 September 2024. Over the past year, it has dropped by -$1.43 billion (-4208.64%). ATHA TTM SG&A is now -6531.07% below its all-time high of $34.03 million, reached on 30 September 2023.ATHA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.3% | -3.4% | -4208.6% |
| 3 y3 years | +396.4% | +6.4% | -7475.0% |
| 5 y5 years | +2245.3% | +1387.6% | -10000.0% |
ATHA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +396.4% | -24.5% | +28.9% | -496.6% | at low |
| 5 y | 5 years | at high | +2245.3% | -24.5% | +1549.7% | -6531.1% | at low |
| alltime | all time | at high | +2245.3% | -24.5% | +1549.7% | -6531.1% | at low |
Athira Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.57 M(+28.9%) | $26.86 M(-1.0%) |
| June 2024 | - | $5.87 M(-8.9%) | $27.13 M(-13.3%) |
| Mar 2024 | - | $6.45 M(-7.3%) | $31.28 M(-6.1%) |
| Dec 2023 | $33.30 M(+2.3%) | $6.96 M(-11.2%) | $33.30 M(-2.1%) |
| Sept 2023 | - | $7.84 M(-21.8%) | $34.03 M(+2.0%) |
| June 2023 | - | $10.03 M(+18.3%) | $33.36 M(+3.9%) |
| Mar 2023 | - | $8.48 M(+10.2%) | $32.10 M(-1.4%) |
| Dec 2022 | $32.55 M(+53.3%) | $7.69 M(+7.3%) | $32.55 M(+4.9%) |
| Sept 2022 | - | $7.17 M(-18.2%) | $31.02 M(+0.2%) |
| June 2022 | - | $8.77 M(-1.8%) | $30.97 M(+15.5%) |
| Mar 2022 | - | $8.93 M(+44.9%) | $26.82 M(+26.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $21.23 M(+216.4%) | $6.16 M(-13.5%) | $21.23 M(+12.0%) |
| Sept 2021 | - | $7.12 M(+54.3%) | $18.96 M(+41.4%) |
| June 2021 | - | $4.61 M(+38.3%) | $13.41 M(+43.1%) |
| Mar 2021 | - | $3.34 M(-14.3%) | $9.37 M(+39.7%) |
| Dec 2020 | $6.71 M(+305.1%) | $3.89 M(+148.4%) | $6.71 M(+104.8%) |
| Sept 2020 | - | $1.57 M(+172.5%) | $3.28 M(+47.7%) |
| June 2020 | - | $575.00 K(-14.8%) | $2.22 M(+35.0%) |
| Mar 2020 | - | $675.00 K(+47.1%) | $1.64 M(+69.7%) |
| Dec 2019 | $1.66 M(+16.6%) | $459.00 K(-9.8%) | $968.00 K(+90.2%) |
| Sept 2019 | - | $509.00 K | $509.00 K |
| Dec 2018 | $1.42 M | - | - |
FAQ
- What is Athira Pharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Athira Pharma?
- What is Athira Pharma annual SG&A year-on-year change?
- What is Athira Pharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Athira Pharma?
- What is Athira Pharma quarterly SG&A year-on-year change?
- What is Athira Pharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Athira Pharma?
- What is Athira Pharma TTM SG&A year-on-year change?
What is Athira Pharma annual selling, general & administrative expenses?
The current annual SG&A of ATHA is $33.30 M
What is the all time high annual SG&A for Athira Pharma?
Athira Pharma all-time high annual selling, general & administrative expenses is $33.30 M
What is Athira Pharma annual SG&A year-on-year change?
Over the past year, ATHA annual selling, general & administrative expenses has changed by +$752.00 K (+2.31%)
What is Athira Pharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of ATHA is $7.57 M
What is the all time high quarterly SG&A for Athira Pharma?
Athira Pharma all-time high quarterly selling, general & administrative expenses is $10.03 M
What is Athira Pharma quarterly SG&A year-on-year change?
Over the past year, ATHA quarterly selling, general & administrative expenses has changed by -$268.00 K (-3.42%)
What is Athira Pharma TTM selling, general & administrative expenses?
The current TTM SG&A of ATHA is -$1.40 B
What is the all time high TTM SG&A for Athira Pharma?
Athira Pharma all-time high TTM selling, general & administrative expenses is $34.03 M
What is Athira Pharma TTM SG&A year-on-year change?
Over the past year, ATHA TTM selling, general & administrative expenses has changed by -$1.43 B (-4208.64%)